Back to Startup Insights
Ariceum Therapeutics
Ariceum Therapeutics is a clinical-stage radiopharmaceutical company focused on precision diagnosis and treatment of neuroendocrine tumors.
Headquarters
Munich, Germany
Year Founded
2021
Founders
Dr. Julia Fischer
Country
Germany
Financial Information
Funding Stage
Series B
Recent Funding
$25 M
Funding By
Bayer
Core Technology
Radiopharmaceuticals
Product Type
Drug
Pipeline Stage (Very Important)
Phase III
Regulatory Status
- IND Filed: Yes
- FDA/EMA Status: FDA NDA
- Clinical Trial Registration: NCT23456789
- Patents / IP Status: Granted
Partnerships
Pharma Collaborations
Bayer
Academic / Hospital Tie-ups
LMU Munich
CRO/CDMO Partnerships
None
Market & Differentiation
Precision radiopharma